Connect with us

Cannabis News

The End of the Hemp Industry? The DEA is Coming for Hemp-Derived Delta-8 THC, And Maybe More Synthetic Cannabinoids

Published

on


DEA bans delta-8 thc

Your Corporate Political Overlords discuss the finer details on how they own you

 

 

Did you hear?

 

The DEA recently released their new updated “slaver’s agreement,” where your  bodily autonomy gets violated and labeled a “crime” – in which you forgo your liberty under the 12th Amendment and become property of the state.

 

Their latest update comes in retaliation to the market’s “loophole”, Delta-8 THC.

 

Allow me to summarize an article originally published in Marijuana Moment.

 

 

The Drug Enforcement Administration (DEA) is at it again, my fellow cannabis enthusiasts. According to recent reports, the DEA is preparing to propose new rules that would classify synthetically manufactured cannabinoids, such as delta-8 THC, as prohibited controlled substances. Oh, joy!

 

During the agency’s Supply Chain Conference, Terrance Boos, the chief of the DEA’s Drug and Chemical Evaluation Section, revealed their plans to modify regulations on cannabis constituents based on recommendations from the U.S. Department of Health and Human Services (HHS). One proposed change is to “decontrol CBD up to 0.1 percent THC.” In other words, they want to loosen the grip on CBD slightly, but don’t get too excited—it’s a minuscule step in the right direction.

 

The intention behind these new rules, they claim, is to provide clarity and eliminate confusion surrounding the legal status of various cannabinoids. Since the federal legalization of hemp and its derivatives under the 2018 Farm Bill, the market for cannabis products has exploded. However, the emergence of intoxicating cannabinoids like delta-8 THC has caused quite the stir, prompting lawmakers in various states to scramble and create a chaotic patchwork of regulations for these products.

 

Here’s the thing, my friends: delta-8 THC does occur naturally in cannabis in trace amounts, and the DEA had previously confirmed that these natural constituents were uncontrolled. But hold on to your hats because they’re about to drop the hammer. The DEA wants to crack down on “synthetic delta-8 THC”, which is produced through a chemical process that converts CBD into this delightful compound.

 

They argue that synthetic tetrahydrocannabinols, like delta-8 THC, are not exempted from the Controlled Substances Act (CSA), unlike their naturally produced counterparts.

 

Basically, they just closed the “loophole” with the legal Delta 8 issue.

 

Now, let’s take a moment to appreciate the sheer brilliance of this move. The DEA, in their infinite wisdom, wants to tighten their grip on a compound that can be obtained naturally from the plant but is suddenly deemed dangerous when synthesized in a lab. It’s almost as if they’re determined to make our lives as difficult as possible while completely disregarding the scientific evidence and the will of the people.

 

But we know that the Controlled Substance Act never utilized Science or Reason at its core. We know that the CSA is merely a tool of the oppressors

 

But fear not, my dear readers, for the battle is not lost. The final rule from the DEA is yet to be unveiled, and we must remain vigilant and united in our fight for cannabis freedom. Additionally, there are potential changes on the horizon with the next iteration of the farm bill and President Biden’s review of marijuana scheduling. These developments could shape the landscape of cannabis regulation and have a profound impact on the industry.

 

However, when it comes to Biden and his ilk – I wouldn’t hold my breath. In fact, those guys are trying to set it up so that Pharma can get main control over the cannabis industry. This is because irrespective of their party colors – they all serve the same masters.

 

In the midst of this regulatory frenzy, it’s crucial to stay informed and engaged. Companies and individuals must pay attention and actively participate in the discussions surrounding these issues.

 

The lack of regulatory guidance from the Food and Drug Administration (FDA) only adds to the confusion. The FDA has yet to establish clear rules for hemp-derived CBD products, leaving companies and consumers in a state of limbo.But then again, this isn’t surprising either.

 

The FDA has the power to reschedule cannabis and provide much-needed regulatory clarity. But alas, they claim they lack the authority to do so without congressional support. Meanwhile, the DEA, who holds the keys to the rescheduling kingdom, insists on relying on the FDA’s scientific review before making any moves. It’s a never-ending loop of finger-pointing and bureaucratic inertia, leaving us stuck in a limbo of uncertainty. Oh, the joys of government bureaucracy at its finest!

 

This is also by design. It’s not an accident that the FDA – which is primarily funded by Pharma – somehow can’t seem to get the “safety profile” of cannabis after decades and decades of research. But magically, almost as if they were paid billions – they could fast track a vaccine that was not effective at stopping transmissions and empirically didn’t perform that much better than natural immunity.

 

But I digress.

 

While we brace ourselves for the DEA’s final rule on synthetic cannabinoids, we must remember that enforcement resources are limited. The FDA is likely to focus on public safety concerns and legality, as demonstrated by their joint enforcement action in Minnesota. The ultimate decision rests with the DEA, and we can only hope they’ll come to their senses and acknowledge the absurdity of their current stance.

 

So, my friends, let us stand together in defiance of the DEA’s attempts to stifle our freedom and enjoyment of cannabis. We must remain informed, engaged, and vocal in our opposition to these draconian regulations.

 

But let’s dive deeper into how this will impact the cannabis industry, especially in states that don’t have cannabis laws on the books.

 

How this change will impact legal THC?

 

Well, in a nutshell, the DEA has given themselves the power to go out and bust up any sales of Delta-8 that “isn’t natural”. How they will prove this is still to be decided, but essentially, you can expect them to conduct raids or at the very least send out “cease and desist” letters to those establishments that are currently selling it.

 

But that is only talking about the legal establishments. The real victims here are the people who need access to cannabis in prohibition states.

 

You see, Delta-8 THC, a cannabinoid derived from hemp, has been providing a legal avenue for individuals, including veterans and those suffering from chronic pain, to access the therapeutic benefits of cannabis without running afoul of strict state laws. It was a glimmer of hope, a ray of light in the darkness of prohibition.

 

But alas, the DEA, in their insatiable need to remain relevant and flex their authority, has decided to crush that hope.

 

By classifying Delta-8 THC as illegal, they have effectively cut off the legal option for those who rely on its medicinal properties. Once again, individuals in prohibition states are forced to go underground, to seek out illicit sources for their cannabis needs. It’s a tragic cycle, my friends, one that perpetuates the black market and denies people access to safe, regulated products.

 

The DEA’s decision is particularly disheartening because it disregards the growing acceptance and tolerance of adult drug use in our society.

 

As more and more states embrace cannabis legalization, it seems the DEA is desperately clinging to the vestiges of a bygone era. Instead of adapting to the changing times and acknowledging the potential benefits of cannabis, they choose to stifle progress and maintain their grip on power.

 

In doing so, the DEA not only undermines the rights of individuals to make informed choices about their own well-being but also perpetuates the harms of the black market. It’s a lose-lose situation, my friends.

 

Those in need of cannabis for medical purposes are left without legal options, and the black market thrives once again, with all its associated dangers and risks.

 

So, we find ourselves in a familiar position, caught in the crossfire of outdated policies and misguided attempts to control what people choose to put in their bodies.

 

 It’s a frustrating reality, but one that only strengthens our resolve to advocate for sensible drug policies and the rights of individuals to access the substances that can improve their quality of life.

 

 

My dear friends, the time has come for a new conversation, a conversation that challenges the outdated notions surrounding drugs, drug use, and individual autonomy. We must question the hypocrisy that exists in our society, where we are allowed to consume unhealthy processed foods and poison ourselves with high-fructose garbage, but somehow lack the intelligence to make informed decisions about other substances.

 

It’s time to recognize that agencies tasked with protecting us from ourselves are unnecessary and often hinder progress. We should have the right to determine what we put into our bodies, as long as we are aware of the risks and benefits involved. The freedom to make choices about our own well-being should extend to all areas of consumption, not just those deemed acceptable by societal norms.

 

Let us be outspoken about these issues, my friends. Let us challenge those who cling to archaic ideas and stand in the way of progress. It is time to evolve beyond the restrictive mindset of the 1900s and embrace a future where individual autonomy is cherished and respected.

 

Together, let us advocate for a society that values personal freedom, informed decision-making, and the right of individuals to determine what is best for their own bodies. Only through open dialogue and a commitment to change can we pave the way for a more enlightened and compassionate approach to drugs and human rights.

 

So, my friends, let us raise our voices, challenge the status quo, and forge a path towards a future where the rights of individuals are paramount. The time for change is now, and together, we can create a society that truly embraces individual autonomy as a sacred right.

 

MORE ON THE DEA OVER-REACH, READ ON…

dea rulings on delta-8 thc hemp derived

THE DEA IS COMING FOR DELTA-8 THC, HHC, AND HEMP-DERIVED PRODUCTS!

 



Source link

Cannabis News

Latest Trump Weed Rumor – Trump Will Federally Deschedule and Decriminalize Cannabis, but Not Legalize It

Published

on

By


trump on marijuana reform

In a recent interview, former New Jersey Governor Chris Christie made headlines by asserting that President-elect Donald Trump will pursue significant reforms in federal policies regarding marijuana and cryptocurrency. As the nation grapples with evolving attitudes toward cannabis and the burgeoning digital currency market, Christie’s predictions have ignited discussions about the potential implications of such changes on both industries. This article delves into Christie’s insights, the current state of marijuana and cryptocurrency regulations, and the broader implications of these anticipated reforms.

 

The Current Landscape of Marijuana Legislation

 

Federal vs. State Laws

Marijuana remains classified as a Schedule I substance under the Controlled Substances Act (CSA), which places it in the same category as heroin and LSD. This classification has created a complex legal landscape where states have moved to legalize cannabis for medical and recreational use, while federal law continues to impose strict prohibitions. As of now, over 30 states have legalized marijuana in some form, leading to a burgeoning industry that generates billions in revenue.

 

Challenges Faced by the Cannabis Industry

 

Despite its legality in many states, the cannabis industry faces significant hurdles due to federal restrictions. These challenges include:

  • Banking Access: Many banks are hesitant to work with cannabis businesses due to fear of federal repercussions, forcing these businesses to operate largely in cash.

  • Taxation Issues: The IRS enforces Section 280E of the tax code, which prohibits businesses engaged in illegal activities from deducting normal business expenses, leading to disproportionately high tax burdens for cannabis companies.

  • Interstate Commerce: The lack of federal legalization prevents cannabis businesses from operating across state lines, limiting their growth potential.

 

Chris Christie’s Perspective on Marijuana Reform

 

Christie, a former presidential candidate known for his tough stance on drugs during his tenure as governor, has evolved his views on marijuana over the years. In his recent statements, he emphasized that Trump is likely to pursue descheduling cannabis, which would remove it from the Schedule I classification. This move would not only provide clarity for businesses operating in legal markets but also open avenues for banking and investment.

 

Christie highlighted that descheduling would allow for a more regulated market where safety standards could be established, thus protecting consumers. He believes that this approach aligns with a growing consensus among Americans who support legalization and recognize the potential benefits of cannabis use for both medical and recreational purposes.

 

The Future of Cryptocurrency Regulation = The Rise of Cryptocurrencies

 

Cryptocurrencies have surged in popularity over the past decade, with Bitcoin leading the charge as the first decentralized digital currency. The market has expanded to include thousands of alternative coins (altcoins), each with unique features and use cases. As cryptocurrencies gain traction among investors and consumers alike, regulatory scrutiny has intensified.

 

Current Regulatory Challenges

 

The cryptocurrency market faces several regulatory challenges that hinder its growth and adoption:

 

  • Lack of Clarity: Regulatory frameworks vary significantly across states and countries, creating confusion for investors and businesses.

  • Fraud and Scams: The rapid growth of cryptocurrencies has led to an increase in fraudulent schemes targeting unsuspecting investors.

  • Consumer Protection: Without clear regulations, consumers are often left vulnerable to risks associated with volatile markets.

 

Christie’s Vision for Crypto Regulation

 

Christie believes that under Trump’s leadership, there will be an effort to find a “sweet spot” for cryptocurrency regulation balancing innovation with consumer protection. He argues that overly stringent regulations could stifle growth in this emerging sector while too little oversight could expose consumers to significant risks.

 

In his view, a balanced regulatory framework would include:

 

1. Clear Definitions: Establishing clear definitions for different types of cryptocurrencies and tokens to differentiate between securities and utility tokens.

2. Consumer Protections: Implementing measures to protect investors from fraud while promoting transparency within the market.

3. Encouraging Innovation: Creating an environment conducive to innovation by allowing startups to thrive without excessive regulatory burdens.

 

Christie’s insights reflect a growing recognition among policymakers that cryptocurrencies are here to stay and that appropriate regulations are necessary to foster growth while safeguarding consumers.

 

Implications of Proposed Reforms

 

Economic Impact

 

The potential reforms proposed by Christie could have far-reaching economic implications:

 

  • Job Creation: Legalizing marijuana at the federal level could lead to significant job creation within the cannabis industry—from cultivation and production to retail sales.

  • Investment Opportunities: Descheduling cannabis would open up investment opportunities for institutional investors who have been hesitant due to federal restrictions.

  • Boosting Local Economies: Legal cannabis markets have proven beneficial for local economies through increased tax revenues and job creation.

 

Similarly, clear regulations around cryptocurrencies could stimulate investment in blockchain technology and related industries, fostering innovation and economic growth.

 

Social Justice Considerations

 

Both marijuana legalization and sensible cryptocurrency regulations have social justice implications:

 

  • Addressing Past Injustices: Legalizing marijuana could help rectify past injustices related to drug enforcement policies that disproportionately affected marginalized communities.

  • Financial Inclusion: Cryptocurrencies offer opportunities for financial inclusion for those underserved by traditional banking systems, particularly in low-income communities.

 

Political Landscape

 

The political landscape surrounding these issues is complex. While there is bipartisan support for marijuana reform among certain lawmakers, challenges remain in overcoming entrenched opposition. Similarly, cryptocurrency regulation has garnered attention from both sides of the aisle but requires collaboration to establish effective frameworks.

 

Conclusion

 

Chris Christie’s predictions about President-elect Donald Trump’s approach to federal marijuana descheduling and cryptocurrency regulation suggest a potential shift in U.S. policy that could significantly reshape both industries. As public opinion evolves on these issues, lawmakers have an opportunity to enact meaningful reforms that promote economic growth while ensuring consumer protection. The anticipated changes could foster a more robust cannabis industry that contributes positively to the economy and addresses social justice concerns, while clear regulatory frameworks for cryptocurrencies could encourage innovation and protect consumers in the digital economy. Stakeholders in both sectors are closely watching these developments, eager to see how potential reforms might impact their futures. While the realization of Christie’s predictions remains uncertain, it’s clear that the conversation around marijuana and cryptocurrency regulation is ongoing and far from settled.

 

TRUMP 2.0 ON CANNABIS REFORM, READ ON…

TRUMP ON MARIJUANA REFORM

TRUMP 2.0 ON FEDERAL CANNABIS REFORM – WHAT DO WE KNOW?

 



Source link

Continue Reading

Cannabis News

Webinar Replay: Post-Election Cannabis Wrap – Smoke ’em if You’ve Got ’em

Published

on

By


On Thursday, November 7th, Vince Sliwoski, Aaron Pelley and Fred Rocafort held a post election discussion “Post-Election Cannabis Wrap – Smoke ’em if You’ve Got ’em”. Watch the replay!

Key Takeaways from the “Smoke ’em if You’ve Got ’em – 2024 Post Election Cannabis Wrap” Webinar:

  1. Panelists:
    • Vince Sliwoski: Oregon Business lawyer specializing in cannabis and commercial real estate.
    • Aaron Pelley: Experienced in cannabis law since Washington’s legalization in 2012.
    • Fred Rocafort: Trademark attorney working closely with the cannabis team.
  2. Election Results Overview:
    • Most 2024 cannabis ballot measures did not pass.
    • Florida, South Dakota, and North Dakota saw failures.
    • Nebraska became the 39th state to legalize cannabis for medical use when it passed two cannabis initiatives, Initiatives 437 and 438.
  3. Federal and State-Level Developments:
    • Medical use is currently legal in 38 states, and 24 states allow recreational use.
    • Republican support for marijuana legalization is growing.
  4. Federal Policy Implications:
    • Schedule III Rescheduling: The process to move cannabis to Schedule III is ongoing, which could significantly impact the industry.
    • Importance of Federal Appointments: The future of cannabis policy depends heavily on who is appointed to key positions in the administration.
  5. International and Domestic Trade:
    • Schedule III status could ease import/export restrictions on cannabis.
    • Unified control of House, Senate, and presidency might expedite legislative progress.
  6. Economic and Industry Impact:
    • Cannabis stocks experienced volatility post-election, reflecting investor uncertainty.
    • Federal legalization and banking reforms are crucial for industry stability and growth.
  7. Future Outlook:
    • The potential for federal rescheduling remains strong, with hearings scheduled for early 2025.
    • State-level initiatives and regulatory developments will continue to shape the industry.

Watch the replay!



Source link

Continue Reading

Cannabis News

I Had Just One Puff

Published

on

By


one puff of a joint a drug test

“How Long Does One Puff of Weed Stay in Your System?”… This topic can be difficult to answer since it is dependent on elements such as the size of the hit and what constitutes a “one hit.” If you take a large bong pull then cough, it might linger in your system for 5-7 days. A moderate dose from a joint can last 3-5 days, whereas a few hits from a vaporizer may last 1-3 days.

 

The length of time that marijuana stays in the body varies based on a number of factors, including metabolism, THC levels, frequency of use, and hydration.

 

Delta-9-tetrahydrocannabinol, or THC, is the primary psychoactive component of cannabis. THC and its metabolites, which remain in your body long after the effects have subsided, are detected by drug tests.

 

Since these metabolites are fat-soluble, they cling to bodily fat molecules. They could thus take a while to fully pass through your system, particularly if your body fat percentage is higher.

 

THC is absorbed by tissues and organs (including the brain, heart, and fat) and converted by the liver into chemicals such as 11-hydroxy-THC and carboxy-THC. Cannabis is eliminated in feces at a rate of around 65%, while urine accounts for 20%. The leftover amount might be kept within the body.

 

THC deposited in bodily tissues ultimately re-enters the circulation and is processed by the liver. For frequent users, THC accumulates in fatty tissues quicker than it can be removed, thus it may be detectable in drug tests for days or weeks following consumption.

 

The detection time varies according to the amount and frequency of cannabis usage. Higher dosages and regular usage result in longer detection times.

 

The type of drug test also affects detection windows. Blood and saliva tests typically detect cannabis metabolites for shorter periods, while urine and hair samples can reveal use for weeks or even months. In some cases, hair tests have detected cannabis use over 90 days after consumption.

 

Detection Windows for Various Cannabis Drug Tests

 

Urine Tests

Among all drug tests, urine testing is the most commonly used method for screening for drug use in an individual.

 

Detection times vary, but a 2017 review suggests the following windows for cannabis in urine after last use:

 

– Single-use (e.g., one joint): up to 3 days

– Moderate use (around 4 times a week): 5–7 days

– Chronic use (daily): 10–15 days

– Chronic heavy use (multiple times daily): over 30 days

 

Blood Tests

Blood tests generally detect recent cannabis use, typically within 2–12 hours after consumption. However, in cases of heavy use, cannabis has been detected up to 30 days later. Chronic heavy use can extend the detection period in the bloodstream.

 

Saliva Tests

THC can enter saliva through secondhand cannabis smoke, but THC metabolites are only present if you’ve personally smoked or ingested cannabis.

 

Saliva testing has a short detection window and can sometimes identify cannabis use on the same day. A 2020 review found that THC was detectable in the saliva of frequent users for up to 72 hours after use, and it may remain in saliva longer than in blood following recent use.

 

In areas where cannabis is illegal, saliva testing is often used for roadside screenings.

 

Hair Tests

Hair follicle tests can detect cannabis use for up to 90 days. After use, cannabinoids reach the hair follicles through small blood vessels and from sebum and sweat surrounding the hair.

 

Hair grows at approximately 0.5 inches per month, so a 1.5-inch segment of hair close to the scalp can reveal cannabis use over the past three months.

 

Factors Affecting THC and Metabolite Retention

 

The length of time THC and its metabolites stay in your system depends on various factors. Some, like body mass index (BMI) and metabolic rate, relate to individual body processing, not the drug itself.

 

Other factors are specific to cannabis use, including:

 

– Dosage: How much you consume

– Frequency: How often you use cannabis

– Method of consumption: Smoking, dabbing, edibles, or sublingual

– THC potency: Higher potency can extend detection time

 

Higher doses and more frequent use generally extend THC retention. Cannabis consumed orally may remain in the system slightly longer than smoked cannabis, and stronger cannabis strains, higher in THC, may also stay detectable for a longer period.

 

How Quickly Do the Effects of Cannabis Set In?

 

When smoking cannabis, effects appear almost immediately, while ingested cannabis may take 1–3 hours to peak.

 

The psychoactive component THC produces a “high” with common effects such as:

 

– Altered senses, including perception of time

– Mood changes

– Difficulty with thinking and problem-solving

– Impaired memory

 

Other short-term effects can include:

– Anxiety and confusion

– Decreased coordination

– Dry mouth and eyes

– Nausea or lightheadedness

– Trouble focusing

– Increased appetite

– Rapid heart rate

– Restlessness and sleepiness

 

In rare cases, high doses may lead to hallucinations, delusions, or acute psychosis.

 

Regular cannabis use may have additional mental and physical effects. While research is ongoing, cannabis use may increase the risk of:

 

– Cognitive issues like memory loss

– Cardiovascular problems including heart disease and stroke

– Respiratory illnesses such as bronchitis or lung infections

– Mood disorders like depression and anxiety

 

Cannabis use during pregnancy can negatively impact fetal growth and development.

 

Duration of Effects

Short-term effects generally taper off within 1–3 hours, but for chronic users, some long-term effects may last days, weeks, or even months. Certain effects may even be permanent.

 

Bottom Line

The amount of time that cannabis remains in your system following a single use varies greatly depending on individual characteristics such as body fat, metabolism, frequency of use, and mode of intake. Frequent users may maintain traces of THC for weeks, whereas infrequent users may test positive for as little as a few days. Hair tests can disclose usage for up to 90 days, while blood and saliva tests identify more recent use. Urine tests are the most popular and have varying detection durations. The duration that THC and its metabolites are detectable will ultimately depend on a number of factors, including dose, strength, and individual body chemistry.

 

PEE IN A CUP COMING UP, READ ON..

how long does weed stay in your urine

HOW LONG DOES WEED STAY IN YOUR URINE FOR A DRUG TEST?



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media